These observations are interesting in the context of our study since we have initiated a longitudinal study to determine which ACR patients with a positive ANA or anti-ENA antibody test that did not meet criteria for an AARD evolve into an AARD such as SLE. Here, BTG3 is linked to systemic lupus erythematosus.